We are live on ! Find out more
STRO icon

Sutro Biopharma
STRO

130 hedge funds and large institutions have $216M invested in Sutro Biopharma in 2024 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $268K | Put options by funds: $121K

109% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 11

65% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 31

17% more capital invested

Capital invested by funds: $185M → $216M (+$31.3M)

9% more funds holding

Funds holding: 119 → 130 (+11)

0.1% less ownership

Funds ownership: 7.72% → 7.63% (-0.1%)

Holders
130
Holders Change
+11
Holders Change %
+9.24%
% of All Funds
1.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
51
Reduced
31
Closed
11
Calls
$268K
Puts
$121K
Net Calls
+$147K
Net Calls Change
+$237K

Top Buyers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$3.19M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$2.84M
3
Goldman Sachs
Goldman Sachs
New York
+$2.73M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.51M
5
Citadel Advisors
Citadel Advisors
Florida
+$1.99M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$9.13M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$5.68M
3
PAM
Panagora Asset Management
Massachusetts
-$2.6M
4
SCM
Suvretta Capital Management
New York
-$2.04M
5
SSA
Schonfeld Strategic Advisors
New York
-$1.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$2.04M -$375K -9,560 -14%
Two Sigma Investments
27
Two Sigma Investments
New York
$1.7M -$46.4K -1,183 -2%
Connor, Clark & Lunn Investment Management (CC&L)
28
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.51M +$1.71M +43,705 New
DM
29
Deerfield Management
New York
$1.25M +$1.41M +35,992 New
UOC
30
UBS O'Connor
Illinois
$1.17M +$248K +6,316 +23%
DCM
31
DAFNA Capital Management
California
$1.14M – – –
AQR Capital Management
32
AQR Capital Management
Connecticut
$1.13M +$165K +4,202 +15%
SSA
33
Schonfeld Strategic Advisors
New York
$981K -$1.37M -35,060 -55%
Morgan Stanley
34
Morgan Stanley
New York
$948K -$53.8K -1,372 -5%
Barclays
35
Barclays
United Kingdom
$945K +$850K +21,676 +385%
Fisher Asset Management
36
Fisher Asset Management
Washington
$939K – – –
LPL Financial
37
LPL Financial
California
$934K +$156K +3,975 +17%
Charles Schwab
38
Charles Schwab
California
$872K +$138K +3,517 +16%
PAM
39
Panagora Asset Management
Massachusetts
$847K -$2.6M -66,269 -73%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$744K -$226K -5,767 -21%
OAC
41
OMERS Administration Corp
Ontario, Canada
$658K +$746K +19,030 New
Fidelity Investments
42
Fidelity Investments
Massachusetts
$654K +$148K +3,770 +25%
Ameriprise
43
Ameriprise
Minnesota
$631K +$3.25K +83 +0.5%
D.E. Shaw & Co
44
D.E. Shaw & Co
New York
$580K +$153K +3,898 +30%
UBS Group
45
UBS Group
Switzerland
$574K +$527K +13,451 +429%
Man Group
46
Man Group
United Kingdom
$567K +$132K +3,365 +26%
SO
47
STRS Ohio
Ohio
$529K -$49K -1,250 -8%
Russell Investments Group
48
Russell Investments Group
United Kingdom
$523K +$90.1K +2,299 +18%
Bank of America
49
Bank of America
North Carolina
$447K +$132K +3,366 +35%
SPA
50
Sherbrooke Park Advisers
New York
$446K +$430K +10,978 +576%
1
2
3 4 5

STRO Hedge Fund Activity: Q3 2024 in Review

130 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Sutro Biopharma (STRO) for Q3 2024, worth a combined $216M — up 17% from $185M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new STRO positions and 11 closed out — a net gain of 12 holders — while 51 added to existing stakes and 31 trimmed.

The largest buyer was Bank of Montreal, opening a new position worth an estimated $3.19M. The largest seller was Millennium Management, cutting an estimated $9.13M.

  • 130 institutional investors held Sutro Biopharma (STRO) as of Q3 2024, up from 119 in Q2 2024.
  • Funds reported $216M of Sutro Biopharma stock for Q3 2024, up 17% quarter-over-quarter.
  • 23 funds opened new Sutro Biopharma positions in Q3 2024 and 11 closed out, a net change of +12 holders.
  • The largest Sutro Biopharma buyer in Q3 2024 was Bank of Montreal, an estimated $3.19M added.
  • The largest Sutro Biopharma seller in Q3 2024 was Millennium Management, an estimated $9.13M sold.

Based on aggregated 13F filings for Q3 2024.